Janet C. Shaw

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

Christopher D. Williams, Joel Z. Stengel, Michael Asike et al. · Gastroenterology · 2010 · 2.2K citations · Full text

Medicine, Internal Medicine, Hepatology +14

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial

Dawn M. Torres, Frances J. Jones, Janet C. Shaw et al. · Hepatology · 2011 · 183 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial

Carly S. Eckard, Renee E. Cole, Joshua Lockwood et al. · Therapeutic Advances in Gastroenterology · 2013 · 154 citations · Full text

Medicine, Nutrition, Pathology +17

Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease

Omar A. Mesarwi, Mi‐Kyung Shin, Shannon Bevans‐Fonti et al. · PLoS ONE · 2016 · 115 citations · Full text

Life Sciences, Pathobiology, Physiology +17